Kopchick JJ - Search Results

1

Pegvisomant, a growth hormone-specific antagonist, undergoes cellular internalization.

Maamra M, Kopchick JJ, Strasburger CJ, Ross RJ. Maamra M, et al. Among authors: kopchick jj. J Clin Endocrinol Metab. 2004 Sep;89(9):4532-7. doi: 10.1210/jc.2003-031781. J Clin Endocrinol Metab. 2004. PMID: 15356058

2

A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes.

Okada S, Chen WY, Wiehl P, Kelder B, Goodman HM, Guller S, Sonenberg M, Kopchick JJ. Okada S, et al. Among authors: kopchick jj. Endocrinology. 1992 Apr;130(4):2284-90. doi: 10.1210/endo.130.4.1547740. Endocrinology. 1992. PMID: 1547740

3

Effects of growth hormone antagonists on 3T3-F442A preadipocyte differentiation.

Xu BC, Chen WY, Gu T, Ridgway D, Wiehl P, Okada S, Kopchick JJ. Xu BC, et al. Among authors: kopchick jj. J Endocrinol. 1995 Jul;146(1):131-9. doi: 10.1677/joe.0.1460131. J Endocrinol. 1995. PMID: 7561609

4

G120R, a human growth hormone antagonist, shows zinc-dependent agonist and antagonist activity on Nb2 cells.

Dattani MT, Hindmarsh PC, Brook CG, Robinson IC, Kopchick JJ, Marshall NJ. Dattani MT, et al. Among authors: kopchick jj. J Biol Chem. 1995 Apr 21;270(16):9222-6. doi: 10.1074/jbc.270.16.9222. J Biol Chem. 1995. PMID: 7721840 Free article.

5

Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice.

Chen NY, Chen WY, Bellush L, Yang CW, Striker LJ, Striker GE, Kopchick JJ. Chen NY, et al. Among authors: kopchick jj. Endocrinology. 1995 Feb;136(2):660-7. doi: 10.1210/endo.136.2.7835300. Endocrinology. 1995. PMID: 7835300

6

Liver and kidney growth hormone (GH) receptors are regulated differently in diabetic GH and GH antagonist transgenic mice.

Chen NY, Chen WY, Kopchick JJ. Chen NY, et al. Among authors: kopchick jj. Endocrinology. 1997 May;138(5):1988-94. doi: 10.1210/endo.138.5.5123. Endocrinology. 1997. PMID: 9112397

7

The human growth hormone antagonist B2036 does not interact with the prolactin receptor.

Goffin V, Bernichtein S, Carrière O, Bennett WF, Kopchick JJ, Kelly PA. Goffin V, et al. Among authors: kopchick jj. Endocrinology. 1999 Aug;140(8):3853-6. doi: 10.1210/endo.140.8.7047. Endocrinology. 1999. PMID: 10433247

8

Discovery and mechanism of action of pegvisomant.

Kopchick JJ. Kopchick JJ. Eur J Endocrinol. 2003 Apr;148 Suppl 2:S21-5. doi: 10.1530/eje.0.148s021. Eur J Endocrinol. 2003. PMID: 12670297 Review.

9

Clinical review 166: Growth hormone receptor antagonists.

Muller AF, Kopchick JJ, Flyvbjerg A, van der Lely AJ. Muller AF, et al. Among authors: kopchick jj. J Clin Endocrinol Metab. 2004 Apr;89(4):1503-11. doi: 10.1210/jc.2002-022049. J Clin Endocrinol Metab. 2004. PMID: 15070905 Review. No abstract available.

10

Discovery and uses of pegvisomant: a growth hormone antagonist.

Berryman DE, Palmer AJ, Gosney ES, Swaminathan S, DeSantis D, Kopchick JJ. Berryman DE, et al. Among authors: kopchick jj. Endokrynol Pol. 2007 Jul-Aug;58(4):322-9. Endokrynol Pol. 2007. PMID: 18058724 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters